Risk factors contributing to a low darunavir plasma concentration

Darunavir is an efficacious drug; however, pharmacokinetic variability has been reported. The objective of this study was to find predisposing factors for low darunavir plasma concentrations in patients starting the once‐ or twice‐daily dosage. Darunavir plasma concentrations from January 2010 till...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Clin Pharmacol
Asıl Yazarlar: Daskapan, Alper, Stienstra, Ymkje, Kosterink, Jos G. W., Bierman, Wouter F. W., van der Werf, Tjip S., Touw, Daan J., Alffenaar, Jan‐Willem C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Pharmacokinetics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809517/
https://ncbi.nlm.nih.gov/pubmed/29077230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13464
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller